1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and AboveRespiratory Syncytial Virus (RSV)Active, not recruitingPhase 1 / Phase 22025-06-06NCT06642558